SILEN-C3, a phase 2 randomized trial with faldaprevir plus pegylated interferon α-2a and ribavirin in treatment-naive hepatitis C virus genotype 1-infected patients (Q41077060)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | SILEN-C3, a phase 2 randomized trial with faldaprevir plus pegylated interferon α-2a and ribavirin in treatment-naive hepatitis C virus genotype 1-infected patients |
scientific article |
Statements
1 reference
SILEN-C3, a phase 2 randomized trial with faldaprevir plus pegylated interferon α-2a and ribavirin in treatment-naive hepatitis C virus genotype 1-infected patients (English)
1 reference
Douglas Dieterich
Tarik Asselah
Dominique Guyader
Marcus Schuchmann
Stefan Mauss
Vlad Ratziu
Peter Ferenci
Dominique Larrey
Andreas Maieron
Jerry O Stern
Melek Ozan
Yakov Datsenko
Wulf Otto Böcher
Gerhard Steinmann
7 April 2014
1 reference